» Articles » PMID: 31829621

Tunable Repression of Key Photosynthetic Processes Using Cas12a CRISPR Interference in the Fast-Growing Cyanobacterium Sp. UTEX 2973

Overview
Journal ACS Synth Biol
Date 2019 Dec 13
PMID 31829621
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cyanobacteria are photoautotrophic prokaryotes that serve as key model organisms to study basic photosynthetic processes and are potential carbon-negative production chassis for commodity and high-value chemicals. The development of new synthetic biology tools and improvement of current ones is a requisite for furthering these organisms as models and production vehicles. CRISPR interference (CRISPRi) allows for targeted gene repression using a DNase-dead Cas nuclease ("dCas"). Here, we describe a titratable dCas12a (dCpf1) CRISPRi system and apply it to repress key photosynthetic processes in the fast-growing cyanobacterium sp. UTEX 2973 (S2973). The system relies on a lac repressor system that retains tight regulation in the absence of inducer (0-10% repression) while maintaining the capability for >90% repression of high-abundance gene targets. We determined that dCas12a is less toxic than dCas9. We tested the efficacy of the system toward eYFP and three native targets in S2973: the phycobilisome antenna, glycogen synthesis, and photosystem I (PSI), an essential part of the photosynthetic electron transport chain in oxygenic photoautotrophs. PSI was knocked down indirectly by repressing the protein factor BtpA involved in stabilizing core PSI proteins. We could reduce cellular PSI titer by 87% under photoautotrophic conditions, and we characterized these cells to gain insights into the response of the strain to the low PSI content. The ability to tightly regulate and time the (de)repression of essential genes will allow for the study of photosynthetic processes that are not accessible using knockout mutants.

Citing Articles

Review of recent advances in improvement strategies for biofuels production from cyanobacteria.

Mescouto V, Ferreira L, Paiva R, Oliveira D, Santana M, da Rocha Filho G Heliyon. 2024; 10(22):e40293.

PMID: 39624284 PMC: 11609329. DOI: 10.1016/j.heliyon.2024.e40293.


Next-generation CRISPR technology for genome, epigenome and mitochondrial editing.

Lau C, Liang Q, Zhu H Transgenic Res. 2024; 33(5):323-357.

PMID: 39158822 DOI: 10.1007/s11248-024-00404-x.


The rise and future of CRISPR-based approaches for high-throughput genomics.

Vercauteren S, Fiesack S, Maroc L, Verstraeten N, Dewachter L, Michiels J FEMS Microbiol Rev. 2024; 48(5).

PMID: 39085047 PMC: 11409895. DOI: 10.1093/femsre/fuae020.


Thermophilic cyanobacteria-exciting, yet challenging biotechnological chassis.

Rasul F, You D, Jiang Y, Liu X, Daroch M Appl Microbiol Biotechnol. 2024; 108(1):270.

PMID: 38512481 PMC: 10957709. DOI: 10.1007/s00253-024-13082-w.


Light and carbon: Synthetic biology toward new cyanobacteria-based living biomaterials.

Goodchild-Michelman I, Church G, Schubert M, Tang T Mater Today Bio. 2023; 19:100583.

PMID: 36846306 PMC: 9945787. DOI: 10.1016/j.mtbio.2023.100583.